Physician

Athar Masood Ansari, M.D.

According to 2025 Medicare claims, Athar Ansari, M.D. (NPI: 1477612877) practices cardiology in the El Centro, CA market, with the plurality of this provider's patient population coming from Imperial, CA. This provider's primary affiliated billing organization is ATHAR M. ANSARI M D INC. (NPI: 1346433059; TIN: 330806800) and primary practice location at 92243-3274.

Ansari's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,555 traditional Medicare patients, billed 34,997 HCPCS/CPT codes, and received $3,561,949 in Medicare payments. The top billing code was 78492 (Nuclear medicine studies of blood flow in heart muscle at rest and with stress). Part D data shows 8,454 prescription claims across 1,320 beneficiaries totaling $1,825,763 in drug costs, led by Entresto (Sacubitril/Valsartan). DME data shows 12 claims. Open Payments data shows 44 records totaling $898. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $3,964,617 and ending at $3,561,949. Concurrently, Part D prescription costs have risen steadily, from $569,138 to $1,825,763. In contrast, DME billing represents a smaller volume and declined steadily, from $128,391 to $1,763.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.6M$5.1M2015 Medicare payment: $3,964,617 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $4,219,966 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $4,310,507 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $5,127,570 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,626,713 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,025,694 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,856,436 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,005,631 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,626,033 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,561,949 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,88753,710$3,964,617
20161,67964,652$4,219,966
20171,86866,605$4,310,507
20182,55370,332$5,127,570
20192,45145,116$3,626,713
20201,81640,529$3,025,694
20212,10856,732$3,856,436
20222,29641,462$3,005,631
20232,57443,201$4,626,033
20242,55534,997$3,561,949

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$913K$1.8M2015 Drug cost: $569,138 (USD; Tot_Drug_Cst)2016 Drug cost: $656,949 (USD; Tot_Drug_Cst)2017 Drug cost: $716,179 (USD; Tot_Drug_Cst)2018 Drug cost: $919,659 (USD; Tot_Drug_Cst)2019 Drug cost: $895,338 (USD; Tot_Drug_Cst)2020 Drug cost: $971,344 (USD; Tot_Drug_Cst)2021 Drug cost: $1,058,806 (USD; Tot_Drug_Cst)2022 Drug cost: $1,037,018 (USD; Tot_Drug_Cst)2023 Drug cost: $1,536,442 (USD; Tot_Drug_Cst)2024 Drug cost: $1,825,763 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20159839,029$569,138
20169739,921$656,949
201798711,120$716,179
20181,21611,239$919,659
20191,1839,022$895,338
20201,0717,947$971,344
20211,0558,143$1,058,806
20221,0067,298$1,037,018
20231,0607,231$1,536,442
20241,3208,454$1,825,763

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$71K$142K2015 Medicare payment: $116,088 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $66,591 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $141,867 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $727 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $2,325 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $3,122 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $2,256 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $4,302 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $3,020 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $459 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
20151957$116,088
20161237$66,591
20172273$141,867
20181955$727
201947197$2,325
202043140$3,122
20213688$2,256
2022N/R100$4,302
2023N/R76$3,020
2024N/R12$459

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
78492Nuclear medicine studies of blood flow in heart muscle at rest and with stress917923$1,135
93306Ultrasound of heart with color-depicted blood flow, rate, direction and valve function1,6201,724$142
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more1,6133,321$83
93000Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report1,3712,344$10
J2785Injection, regadenoson, 0.1 mg9213,708$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EntrestoSacubitril/Valsartan71133,711$689,303
EliquisApixaban42719,239$372,827
XareltoRivaroxaban2149,145$170,430
Repatha SureclickEvolocumab1836,192$115,264
Praluent PenAlirocumab1113,862$64,307

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E0630Patient lift, hydraulic or mechanical, includes any seat, sling, strap(s) or pad(s)YN/R12$459

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.44$898Merck Sharp & Dohme LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Athar Masood Ansari, M.D.?

Tedicare shows public-source Medicare data for Athar Masood Ansari, M.D. (NPI 1477612877), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Athar Masood Ansari, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Athar Masood Ansari, M.D.?

Athar Masood Ansari, M.D. is linked to ATHAR M. ANSARI M D INC. (billing NPI 1346433059) in the available physician profile data.

Does Athar Masood Ansari, M.D. have Open Payments data?

Athar Masood Ansari, M.D. has 44 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.